Bullseye Asset Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-131,718
Closed -$2.41M 67
2024
Q1
$2.41M Hold
131,718
1.13% 35
2023
Q4
$1.62M Buy
131,718
+20,000
+18% +$188K 0.77% 51
2023
Q3
$1.68M Buy
111,718
+31,816
+40% +$662K 0.93% 43
2023
Q2
$2.6M Buy
79,902
+8,250
+12% +$301K 1.3% 33
2023
Q1
$2.8M Hold
71,652
1.43% 30
2022
Q4
$3.79M Hold
71,652
2.05% 16
2022
Q3
$3.23M Sell
71,652
-1,182
-2% -$50.8K 1.87% 17
2022
Q2
$2.65M Buy
72,834
+103
+0.1% +$3.74K 1.49% 26
2022
Q1
$3M Hold
72,731
1.38% 32
2021
Q4
$3.05M Hold
72,731
1.21% 34
2021
Q3
$4M Sell
72,731
-381
-0.5% -$19.9K 1.39% 29
2021
Q2
$3.5M Buy
73,112
+15,000
+26% +$764K 1.18% 39
2021
Q1
$2.94M Hold
58,112
1.1% 42
2020
Q4
$3.66M Sell
58,112
-714
-1% -$44.3K 1.36% 28
2020
Q3
$3.95M Sell
58,826
-57
-0.1% -$3.11K 1.8% 15
2020
Q2
$2.47M Buy
58,883
+52,965
+895% +$2.03M 1.32% 30
2020
Q1
$186K Sell
5,918
-82
-1% -$3.28K 0.22% 68
2019
Q4
$242K Buy
+6,000
New +$210K 0.23% 66

Other funds holding SILK

Bullseye Asset Management's SILK Position: Q2 2024 in Review

Bullseye Asset Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2024, closing a stake of 131,718 shares — an estimated $2.41M sold.

Bullseye Asset Management first reported a position in SILK in Q4 2019 and held it in 18 quarters. The position peaked at $4M in Q3 2021. 172 funds tracked by Wall St. Rank hold SILK as of Q2 2024.

  • Bullseye Asset Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Bullseye Asset Management sold 131,718 Silk Road Medical, Inc. Common Stock shares in Q2 2024, an estimated $2.41M.
  • Bullseye Asset Management first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2019 and held it in 18 quarters.
  • Bullseye Asset Management's Silk Road Medical, Inc. Common Stock position peaked at $4M in Q3 2021.
  • 172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2024.

Based on Bullseye Asset Management's 13F filing for Q2 2024, filed 15 Aug 2024.